Page last updated: 2024-10-25

deferoxamine and Connective Tissue Diseases

deferoxamine has been researched along with Connective Tissue Diseases in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Connective Tissue Diseases: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geffriaud, C1
Allinne, E1
Page, B1
Zingraff, J1
Jucquel, JP1
Bardin, T1
Drüeke, TB1

Other Studies

1 other study available for deferoxamine and Connective Tissue Diseases

ArticleYear
Decrease of tumor-like calcification in uremia despite aggravation of secondary hyperparathyroidism: a case report.
    Clinical nephrology, 1992, Volume: 38, Issue:3

    Topics: Aluminum; Calcinosis; Chelation Therapy; Connective Tissue Diseases; Deferoxamine; Female; Humans; H

1992